MIT, Recursion, and NVIDIA Launch Boltz-2: Open-Source AI Model Sets New Standard for Binding Affinity Prediction

Boltz-2 is the first biomolecular co-folding model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free...

June 09, 2025 | Monday | News
Augustine Therapeutics Doses First Patient in Phase I Trial of Novel HDAC6 Inhibitor for Charcot-Marie-Tooth Disease

Augustine Therapeutics NV (“Augustine” or “the Company”), a biotechnology company focused on developing new therapies for neuromu...

May 28, 2025 | Wednesday | News
Sanofi Opens $130M U.S. Flagship Office in Morristown to Drive Innovation, Collaboration, and Community Impact

Sanofi  announces the formal opening of the company's new flagship US offices, unveiling a state-of-the-art modern workplace fostering collaboration...

May 23, 2025 | Friday | News
Silo Pharma Partners with Resyca for Nasal Spray Device Study to Advance PTSD Treatment SPC-15

Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel ther...

May 22, 2025 | Thursday | News
Qosina Partners with Sealed Air to Expand Bioprocessing Portfolio with NEXCEL® BIO1250 High-Performance Bag Film

Qosina, a global leader in the distribution of single-use medical and biopharmaceutical components, is proud to announce a new strategic partnership with...

May 09, 2025 | Friday | News
Lantheus to Divest SPECT Business to SHINE Technologies Parent, Illuminated Holdings, in Strategic Refocus on PET and Radiopharmaceutical Innovation

Lantheus Holdings, Inc.the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better ...

May 07, 2025 | Wednesday | News
Stablepharma Doses First Participant in Phase 1 Trial of Fridge-Free Tetanus and Diphtheria Vaccine, SPVX02

 Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheri...

April 29, 2025 | Tuesday | News
ImmVira Presents Promising Phase I Results for Oncolytic HSV Therapy MVR-C5252 in Recurrent Malignant Glioma at AACR 2025

From April 25 to April 30, 2025, U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus ("oHSV") product MVR-...

April 28, 2025 | Monday | News
Debiopharm and Oncodesign Services Partner to Advance Preclinical Radioimmunotherapy Using AbYlink™ Bioconjugation Technology

Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer an...

April 28, 2025 | Monday | News
MDDAP Launches New Certification Pathway to Empower MedTech Professionals

MDDAP is empowering professionals with new opportunities to excel in the medical device sector through a cutting-edge learning pathway designed for the Vol...

April 25, 2025 | Friday | News
Argent BioPharma Enters German Market with CannEpil® and CogniCann® Following Regulatory Approval

Argent BioPharma Ltd. , a clinical-stage biopharmaceutical company specializing in neuroimmune therapies, is pleased to announce its official entry into th...

April 24, 2025 | Thursday | News
Regeneron Expands U.S. Manufacturing with $3B+ Fujifilm Partnership to Boost Biologics Capacity

Regeneron Pharmaceuticals, Inc.  announced a significant expansion of its manufacturing capacity through a new agreement with FUJIFILM Diosynth Biotec...

April 23, 2025 | Wednesday | News
Roche to Invest $50 Billion in U.S. Operations, Boosting Manufacturing, R&D, and Job Creation

Roche  announced  that it will invest USD 50 billion into the United States of America in the next five years. These investments further strength...

April 23, 2025 | Wednesday | News
Henlius Hosts World R&D Day 2025, Showcasing Innovation and Global Collaboration Under "Collaborate to Create" Theme

 Henlius  celebrated its World R&D Day 2025, under the theme "Collaborate to Create", bringing together senior executives, experts and indust...

April 21, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close